$TRXC The exodus of talent is the canary in the coal mine for the health or diseased nature of a failing company. Glenn Warren has left TRXC. Good luck to all. It's disappointing to see this one fail. The lesson here is: regardless of how strong the product might be, management determines chances for adoption in med dev.
  • 2

    Get The Stocktwits Daily Rip

    ©2020 StockTwits, Inc. All rights reserved.
    Market Data by Xignite and BATS BZX Real-Time Price

    Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc.
    Investing in securities products involves risk, including possible loss of principal.
    Please read important legal disclosures.